Trials / Completed
CompletedNCT05588596
Intervention Program to Address PTSD in People Living With HIV
Developing and Validating an Integrative Model Incorporating Mindfulness-based Resilience Intervention to Address Post-Traumatic Stress Disorder in People Living With HIV
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this randomised controlled trial is to evaluate the efficacy of an integrated intervention program on post-traumatic stress disorder (PTSD) symptoms and related physiological and psychological indicators of people living with HIV (PLWH). The main question it aims to answer are: * to evaluate the efficacy of the intervention program on PTSD symptoms and related physiological and psychological indicators of PLWH through empirical research. * to analyze the mechanism of the intervention. Eligible PLWH were recruited and randomly divided as intervention group and control group. The efficacy of Trauma Resiliency Mindfulness-Informed Intervention on PTSD symptoms and related physiological and psychological indicators in PLWH was evaluated at baseline, after intervention, and 3 months after intervention through this randomized controlled trial. Researchers compared the intervention group and control group to see if it was feasible and had potential clinical value to introduce the Trauma Resiliency Mindfulness-Informed intervention program into the management of PLWH in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Trauma Resiliency Mindfulness-Informed Intervention | The total duration of the intervention was once a week for eight weeks. The aim of the intervention was to teach patients a range of trauma recovery mindfulness skills |
Timeline
- Start date
- 2020-05-03
- Primary completion
- 2021-01-30
- Completion
- 2021-03-30
- First posted
- 2022-10-20
- Last updated
- 2022-10-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05588596. Inclusion in this directory is not an endorsement.